Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial-Reference-Cited by-同舟云学术

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial

Published:2018-10-22 Issue:1 Volume:18 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Lee Wonjae,Suh Jung-Won,Park Jin Joo,Yoon Chang-Hwan,Cho Young-Seok,Youn Tae-Jin^ORCID,Chae In-Ho

Funder

Handok Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12872-018-0938-6.pdf

Reference31 articles.

1. Aradi D, Komocsi A, Vorobcsuk A, Rideg O, Tokes-Fuzesi M, Magyarlaki T, Horvath IG, Serebruany VL. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis. Am Heart J. 2010;160(3):543–51.

2. Mangiacapra F, Barbato E, Patti G, Gatto L, Vizzi V, Ricottini E, D'Ambrosio A, Wijns W, Di Sciascio G. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2010;3(3):318–23.

3. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336(24):1689–96.

4. Lindholm D, Varenhorst C, Cannon CP, Harrington RA, Himmelmann A, Maya J, Husted S, Steg PG, Cornel JH, Storey RF, et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014.

5. Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van’t Hof A, Berdan LG, Lee KL, Strony JT, et al. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes. N Engl J Med. 2009;360(21):2176–90.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of pre stenting intracoronary tirofiban followed by infusion in angiographically proven large thrombus burden : A randomized controlled study;Annales de Cardiologie et d'Angéiologie;2023-10

2. Inter-/intra-molecular interactions, preferential solvation, and dissolution and transfer property for tirofiban in aqueous co-solvent mixtures;Journal of Molecular Liquids;2022-09

3. Solubility Determination and Modeling for Tirofiban in Several Mixed Solvents at 278.15–323.15 K;Journal of Chemical & Engineering Data;2020-07-07